APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C13 Stable Isotope Labeled Biomolecules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global C13 Stable Isotope Labeled Biomolecules Market Outlook and Growth Opportunities 2026

Report ID 173973530422 December 2025197 pages

Choose your research edition.

Industry ResearchC13 Stable Isotope Labeled Biomolecules Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal C13 Stable Isotope Labeled Biomolecules Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal C13 Stable Isotope Labeled Biomolecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C13 Stable Isotope Labeled Biomolecules Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C13 Stable Isotope Labeled Biomolecules Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global C13 Stable Isotope Labeled Biomolecules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the C13 Stable Isotope Labeled Biomolecules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the C13 Stable Isotope Labeled Biomolecules market include Cambridge Isotope Laboratories, Icon Isotopes, IsoLife BV, LGC Standards, Medical Isotopes, Omicron Biochemicals, Sigma-Aldrich, Toronto Research Chemicals and WITEGA Laboratorien, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global C13 Stable Isotope Labeled Biomolecules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C13 Stable Isotope Labeled Biomolecules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C13 Stable Isotope Labeled Biomolecules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the C13 Stable Isotope Labeled Biomolecules market size, projected growth trends, production technologies, key applications, and end-use industries.

C13 Stable Isotope Labeled Biomolecules Segment by Company

Cambridge Isotope Laboratories

Icon Isotopes

IsoLife BV

LGC Standards

Medical Isotopes

Omicron Biochemicals

Sigma-Aldrich

Toronto Research Chemicals

WITEGA Laboratorien

Thermo Fisher Scientific

C13 Stable Isotope Labeled Biomolecules Segment by Type

Medical C13 Stable Isotope Labeled Biomolecules

Others

C13 Stable Isotope Labeled Biomolecules Segment by Application

Medical

Scientific Research

Industrial

Others

C13 Stable Isotope Labeled Biomolecules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global C13 Stable Isotope Labeled Biomolecules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions C13 Stable Isotope Labeled Biomolecules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify C13 Stable Isotope Labeled Biomolecules significant trends, drivers, influence factors in global and regions.

6. To analyze C13 Stable Isotope Labeled Biomolecules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C13 Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C13 Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C13 Stable Isotope Labeled Biomolecules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the C13 Stable Isotope Labeled Biomolecules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global C13 Stable Isotope Labeled Biomolecules industry.

Chapter 3: Detailed analysis of C13 Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of C13 Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of C13 Stable Isotope Labeled Biomolecules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. C13 Stable Isotope Labeled Biomolecules Industry Trends Table 2. C13 Stable Isotope Labeled Biomolecules Industry Drivers Table 3. C13 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges Table 4. C13 Stable Isotope Labeled Biomolecules Industry Restraints Table 5. Global C13 Stable Isotope Labeled Biomolecules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global C13 Stable Isotope Labeled Biomolecules Revenue Share by Company (2021-2026) Table 7. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Company (k tons) & (2021-2026) Table 8. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Company (2021-2026) Table 9. Global C13 Stable Isotope Labeled Biomolecules Average Price (US$/ton) of Company (2021-2026) Table 10. Global C13 Stable Isotope Labeled Biomolecules Company Ranking, (2024-2026) & (USD Million) Table 11. Global C13 Stable Isotope Labeled Biomolecules Key Company Manufacturing Base & Headquarters Table 12. Global C13 Stable Isotope Labeled Biomolecules Company, Product Type & Application Table 13. Global C13 Stable Isotope Labeled Biomolecules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global C13 Stable Isotope Labeled Biomolecules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Medical C13 Stable Isotope Labeled Biomolecules Table 18. Significant Companies of Others Table 19. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 20. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Type (2021-2026) & (k tons) Table 21. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Type (2027-2032) & (k tons) Table 22. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Type (2021-2026) Table 23. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Type (2027-2032) Table 24. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type (2021-2026) Table 28. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medical Table 30. Significant Companies of Scientific Research Table 31. Significant Companies of Industrial Table 32. Significant Companies of Others Table 33. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 34. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Application (2021-2026) & (k tons) Table 35. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Application (2027-2032) & (k tons) Table 36. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Application (2021-2026) Table 37. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Application (2027-2032) Table 38. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application (2021-2026) Table 42. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application (2027-2032) Table 43. Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 44. Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2021-2026) & (k tons) Table 45. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2021-2026) Table 46. Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2027-2032) & (k tons) Table 47. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2027-2032) Table 48. Global C13 Stable Isotope Labeled Biomolecules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Region (2021-2026) Table 51. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Region (2027-2032) Table 53. Global C13 Stable Isotope Labeled Biomolecules Market Average Price (US$/ton) by Region (2021-2026) Table 54. Global C13 Stable Isotope Labeled Biomolecules Market Average Price (US$/ton) by Region (2027-2032) Table 55. Global C13 Stable Isotope Labeled Biomolecules Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 58. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2026) Table 59. Global C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 60. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2027-2032) Table 61. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global C13 Stable Isotope Labeled Biomolecules Sales Value Market Share by Country (2021-2026) Table 63. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global C13 Stable Isotope Labeled Biomolecules Sales Value Market Share by Country (2027-2032) Table 65. Cambridge Isotope Laboratories Company Information Table 66. Cambridge Isotope Laboratories Business Overview Table 67. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 69. Cambridge Isotope Laboratories Recent Development Table 70. Icon Isotopes Company Information Table 71. Icon Isotopes Business Overview Table 72. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 74. Icon Isotopes Recent Development Table 75. IsoLife BV Company Information Table 76. IsoLife BV Business Overview Table 77. IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 79. IsoLife BV Recent Development Table 80. LGC Standards Company Information Table 81. LGC Standards Business Overview Table 82. LGC Standards C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 84. LGC Standards Recent Development Table 85. Medical Isotopes Company Information Table 86. Medical Isotopes Business Overview Table 87. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 89. Medical Isotopes Recent Development Table 90. Omicron Biochemicals Company Information Table 91. Omicron Biochemicals Business Overview Table 92. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 94. Omicron Biochemicals Recent Development Table 95. Sigma-Aldrich Company Information Table 96. Sigma-Aldrich Business Overview Table 97. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 99. Sigma-Aldrich Recent Development Table 100. Toronto Research Chemicals Company Information Table 101. Toronto Research Chemicals Business Overview Table 102. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 104. Toronto Research Chemicals Recent Development Table 105. WITEGA Laboratorien Company Information Table 106. WITEGA Laboratorien Business Overview Table 107. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 109. WITEGA Laboratorien Recent Development Table 110. Thermo Fisher Scientific Company Information Table 111. Thermo Fisher Scientific Business Overview Table 112. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 114. Thermo Fisher Scientific Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. C13 Stable Isotope Labeled Biomolecules Distributors List Table 118. C13 Stable Isotope Labeled Biomolecules Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. C13 Stable Isotope Labeled Biomolecules Product Image Figure 2. Global C13 Stable Isotope Labeled Biomolecules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032) & (US$ Million) Figure 4. Global C13 Stable Isotope Labeled Biomolecules Sales (2021-2032) & (k tons) Figure 5. Global C13 Stable Isotope Labeled Biomolecules Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global C13 Stable Isotope Labeled Biomolecules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Medical C13 Stable Isotope Labeled Biomolecules Image Figure 10. Others Image Figure 11. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 12. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Type (2021-2032) Figure 14. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type (2021-2032) Figure 17. Medical Image Figure 18. Scientific Research Image Figure 19. Industrial Image Figure 20. Others Image Figure 21. Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 22. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Application (2021-2032) Figure 24. Global C13 Stable Isotope Labeled Biomolecules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application (2021-2032) Figure 27. Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 28. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global C13 Stable Isotope Labeled Biomolecules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032) & (US$ Million) Figure 32. North America C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032) & (US$ Million) Figure 34. Europe C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032) & (US$ Million) Figure 38. South America C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. C13 Stable Isotope Labeled Biomolecules Value Chain Figure 126. Manufacturing Cost Structure Figure 127. C13 Stable Isotope Labeled Biomolecules Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Medical C13 Stable Isotope Labeled Biomolecules
  • Others
Applications
  • Medical
  • Scientific Research
  • Industrial
  • Others
Companies covered
  • Cambridge Isotope Laboratories
  • Icon Isotopes
  • IsoLife BV
  • LGC Standards
  • Medical Isotopes
  • Omicron Biochemicals
  • Sigma-Aldrich
  • Toronto Research Chemicals
  • WITEGA Laboratorien
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032)
  4. 1.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales Volume (2021-2032)
  5. 1.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 C13 Stable Isotope Labeled Biomolecules Market Dynamics
  1. 2.1 C13 Stable Isotope Labeled Biomolecules Industry Trends
  2. 2.2 C13 Stable Isotope Labeled Biomolecules Industry Drivers
  3. 2.3 C13 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges
  4. 2.4 C13 Stable Isotope Labeled Biomolecules Industry Restraints
3 C13 Stable Isotope Labeled Biomolecules Market by Company
  1. 3.1 Global C13 Stable Isotope Labeled Biomolecules Company Revenue Ranking in 2025
  2. 3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Company (2021-2026)
  3. 3.3 Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Company (2021-2026)
  4. 3.4 Global C13 Stable Isotope Labeled Biomolecules Average Price by Company (2021-2026)
  5. 3.5 Global C13 Stable Isotope Labeled Biomolecules Company Ranking (2024-2026)
  6. 3.6 Global C13 Stable Isotope Labeled Biomolecules Company Manufacturing Base and Headquarters
  7. 3.7 Global C13 Stable Isotope Labeled Biomolecules Company Product Type and Application
  8. 3.8 Global C13 Stable Isotope Labeled Biomolecules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global C13 Stable Isotope Labeled Biomolecules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 C13 Stable Isotope Labeled Biomolecules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 C13 Stable Isotope Labeled Biomolecules Market by Type
  1. 4.1 C13 Stable Isotope Labeled Biomolecules Type Introduction
  2. 4.1.1 Medical C13 Stable Isotope Labeled Biomolecules
  3. 4.1.2 Others
  4. 4.2 Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Type
  5. 4.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Type
  9. 4.3.1 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Type (2021-2032)
  11. 4.3.3 Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type (2021-2032)
5 C13 Stable Isotope Labeled Biomolecules Market by Application
  1. 5.1 C13 Stable Isotope Labeled Biomolecules Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Scientific Research
  4. 5.1.3 Industrial
  5. 5.1.4 Others
  6. 5.2 Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Application
  7. 5.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales Volume by Application (2021-2032)
  9. 5.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales Volume Share by Application (2021-2032)
  10. 5.3 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Application
  11. 5.3.1 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Application (2021-2032)
  13. 5.3.3 Global C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application (2021-2032)
6 C13 Stable Isotope Labeled Biomolecules Regional Sales and Value Analysis
  1. 6.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2021-2032)
  3. 6.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021-2026
  4. 6.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2027-2032)
  5. 6.3 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Region (2021-2032)
  7. 6.4.1 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Region: 2021-2026
  8. 6.4.2 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Region (2027-2032)
  9. 6.5 Global C13 Stable Isotope Labeled Biomolecules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032)
  12. 6.6.2 North America C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032)
  15. 6.7.2 Europe C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032)
  21. 6.9.2 South America C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa C13 Stable Isotope Labeled Biomolecules Sales Value Share by Country, 2025 VS 2032
7 C13 Stable Isotope Labeled Biomolecules Country-level Sales and Value Analysis
  1. 7.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  4. 7.3.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026)
  5. 7.3.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032)
  6. 7.4 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Country (2021-2032)
  7. 7.4.1 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Country (2021-2026)
  8. 7.4.2 Global C13 Stable Isotope Labeled Biomolecules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt C13 Stable Isotope Labeled Biomolecules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt C13 Stable Isotope Labeled Biomolecules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt C13 Stable Isotope Labeled Biomolecules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cambridge Isotope Laboratories
  2. 8.1.1 Cambridge Isotope Laboratories Company Information
  3. 8.1.2 Cambridge Isotope Laboratories Business Overview
  4. 8.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio
  6. 8.1.5 Cambridge Isotope Laboratories Recent Developments
  7. 8.2 Icon Isotopes
  8. 8.2.1 Icon Isotopes Company Information
  9. 8.2.2 Icon Isotopes Business Overview
  10. 8.2.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
  12. 8.2.5 Icon Isotopes Recent Developments
  13. 8.3 IsoLife BV
  14. 8.3.1 IsoLife BV Company Information
  15. 8.3.2 IsoLife BV Business Overview
  16. 8.3.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio
  18. 8.3.5 IsoLife BV Recent Developments
  19. 8.4 LGC Standards
  20. 8.4.1 LGC Standards Company Information
  21. 8.4.2 LGC Standards Business Overview
  22. 8.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio
  24. 8.4.5 LGC Standards Recent Developments
  25. 8.5 Medical Isotopes
  26. 8.5.1 Medical Isotopes Company Information
  27. 8.5.2 Medical Isotopes Business Overview
  28. 8.5.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
  30. 8.5.5 Medical Isotopes Recent Developments
  31. 8.6 Omicron Biochemicals
  32. 8.6.1 Omicron Biochemicals Company Information
  33. 8.6.2 Omicron Biochemicals Business Overview
  34. 8.6.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
  36. 8.6.5 Omicron Biochemicals Recent Developments
  37. 8.7 Sigma-Aldrich
  38. 8.7.1 Sigma-Aldrich Company Information
  39. 8.7.2 Sigma-Aldrich Business Overview
  40. 8.7.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio
  42. 8.7.5 Sigma-Aldrich Recent Developments
  43. 8.8 Toronto Research Chemicals
  44. 8.8.1 Toronto Research Chemicals Company Information
  45. 8.8.2 Toronto Research Chemicals Business Overview
  46. 8.8.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
  48. 8.8.5 Toronto Research Chemicals Recent Developments
  49. 8.9 WITEGA Laboratorien
  50. 8.9.1 WITEGA Laboratorien Company Information
  51. 8.9.2 WITEGA Laboratorien Business Overview
  52. 8.9.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio
  54. 8.9.5 WITEGA Laboratorien Recent Developments
  55. 8.10 Thermo Fisher Scientific
  56. 8.10.1 Thermo Fisher Scientific Company Information
  57. 8.10.2 Thermo Fisher Scientific Business Overview
  58. 8.10.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 C13 Stable Isotope Labeled Biomolecules Value Chain Analysis
  2. 9.1.1 C13 Stable Isotope Labeled Biomolecules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 C13 Stable Isotope Labeled Biomolecules Sales Mode & Process
  6. 9.2 C13 Stable Isotope Labeled Biomolecules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 C13 Stable Isotope Labeled Biomolecules Distributors
  9. 9.2.3 C13 Stable Isotope Labeled Biomolecules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst